File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chronic haloperidol treatment decreases preproenkephalin mRNA in the anterior pituitary: A study by solution-hybridization-RNase protection assay

TitleChronic haloperidol treatment decreases preproenkephalin mRNA in the anterior pituitary: A study by solution-hybridization-RNase protection assay
Authors
Issue Date1996
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/neulet
Citation
Neuroscience Letters, 1996, v. 221 n. 1, p. 66-68 How to Cite?
AbstractBy solution-hybridization-RNase protection assay, the preproenkephalin (PPek) mRNA in the anterior pituitary (AL) of male rats was found to decrease by 42% after 3 weeks haloperidol treatment. It is concluded that dopamine may stimulate the AL enkephalinergic system at the level of gene expression.
Persistent Identifierhttp://hdl.handle.net/10722/171635
ISSN
2015 Impact Factor: 2.107
2015 SCImago Journal Rankings: 1.035
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTang, Fen_US
dc.contributor.authorLau, SMen_US
dc.date.accessioned2012-10-30T06:16:05Z-
dc.date.available2012-10-30T06:16:05Z-
dc.date.issued1996en_US
dc.identifier.citationNeuroscience Letters, 1996, v. 221 n. 1, p. 66-68en_US
dc.identifier.issn0304-3940en_US
dc.identifier.urihttp://hdl.handle.net/10722/171635-
dc.description.abstractBy solution-hybridization-RNase protection assay, the preproenkephalin (PPek) mRNA in the anterior pituitary (AL) of male rats was found to decrease by 42% after 3 weeks haloperidol treatment. It is concluded that dopamine may stimulate the AL enkephalinergic system at the level of gene expression.en_US
dc.languageengen_US
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/neuleten_US
dc.relation.ispartofNeuroscience Lettersen_US
dc.rightsNeuroscience Letters. Copyright © Elsevier Ireland Ltd.-
dc.subject.meshAnimalsen_US
dc.subject.meshDopamine Antagonists - Pharmacologyen_US
dc.subject.meshElectrophoresis, Polyacrylamide Gelen_US
dc.subject.meshEnkephalins - Analysis - Geneticsen_US
dc.subject.meshGene Expression - Drug Effectsen_US
dc.subject.meshHaloperidol - Pharmacologyen_US
dc.subject.meshMaleen_US
dc.subject.meshNucleic Acid Hybridizationen_US
dc.subject.meshPituitary Gland - Chemistry - Drug Effects - Physiologyen_US
dc.subject.meshProtein Precursors - Analysis - Geneticsen_US
dc.subject.meshRna, Messenger - Analysis - Metabolismen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, Sprague-Dawleyen_US
dc.subject.meshRibonucleasesen_US
dc.subject.meshTime Factorsen_US
dc.titleChronic haloperidol treatment decreases preproenkephalin mRNA in the anterior pituitary: A study by solution-hybridization-RNase protection assayen_US
dc.typeArticleen_US
dc.identifier.emailTang, F:ftang@hkucc.hku.hken_US
dc.identifier.authorityTang, F=rp00327en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S0304-3940(96)13274-2en_US
dc.identifier.pmid9014182-
dc.identifier.scopuseid_2-s2.0-0030604222en_US
dc.identifier.hkuros26039-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0030604222&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume221en_US
dc.identifier.issue1en_US
dc.identifier.spage66en_US
dc.identifier.epage68en_US
dc.identifier.isiWOS:A1996WD29400017-
dc.publisher.placeIrelanden_US
dc.identifier.scopusauthoridTang, F=7201979770en_US
dc.identifier.scopusauthoridLau, SM=16740565000en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats